Terminology Service for NFDI4Health
All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Stannous Chloride | NCIT_C74343 | |
| Laurocapram | NCIT_C74344 | [A percutaneous enhancer. Upon application to the skin, laurocapram interacts with lipids in the stratum corneum and may enhance the ability of the skin to absorb a hydrophilic chemical.] |
| Adjuvant | NCIT_C2140 | [An agent that enhances the activity or therapeutic effect of another pharmacologic substance without having much, if any, therapeutic impact by itself.] |
| Amipizone | NCIT_C74345 | |
| Catenin Alpha-1 | NCIT_C88987 | [Catenin alpha-1 (906 aa, ~100 kDa) is encoded by the human CTNNA1 gene. This protein is involved in the mediation of interactions between cadherins and the actin cytoskeleton.] |
| Cytoskeletal Protein | NCIT_C16492 | [A protein that is a structural part of the cytoskeleton. These proteins are involved in cell shape, organelle and protein localization, cell movement, cell division, endocytosis, exocytosis, and signal transduction.] |
| LRRTM2 Gene | NCIT_C88988 | [This gene may play a role in the development of the nervous system.] |
| LRRTM2 wt Allele | NCIT_C88989 | [Human LRRTM2 wild-type allele is located in the vicinity of 5q31.2 and is approximately 6 kb in length. This allele, which encodes leucine-rich repeat transmembrane neuronal protein 2, may be involved in both the development and maintenance of the nervous system.] |
| Stage III Nasopharyngeal Carcinoma AJCC v7 | NCIT_C88983 | [Stage III includes: (T1, N2, M0); (T2, N2, M0); (T3, N0, M0); (T3, N1, M0); (T3, N2, M0). T1: Nasopharyngeal cancer with tumor confined to the nasopharynx, or tumor extending to oropharynx and/or nasal cavity without parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. T2: Nasopharyngeal cancer with parapharyngeal extension. Parapharyngeal extension denotes posterolateral infiltration of tumor. T3: Nasopharyngeal cancer with tumor involving bony structures of skull base and/or paranasal sinuses. N0: No regional lymph node metastasis. N1: Nasopharyngeal cancer with unilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa, and/or unilateral or bilateral, retropharyngeal lymph nodes, 6 cm or less in greatest dimension. Midline nodes are considered ipsilateral nodes. N2: Nasopharyngeal cancer with bilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. Midline nodes are considered ipsilateral nodes. M0: No distant metastasis. (AJCC 7th ed.)] |
| Stage III Pharyngeal Cancer | NCIT_C8770 | [Stage III carcinoma of the pharynx according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.] |
| Stage IV Nasopharyngeal Carcinoma AJCC v7 | NCIT_C88984 | [Stage IV includes: IVA: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0); IVB (Any T, N3, M0); IVC (Any T, Any N, M1). T4: Nasopharyngeal cancer with intracranial extension and/or involvement of cranial nerves, hypopharynx, orbit, or with extension to the infratemporal fossa/masticator space. N0: No regional lymph node metastasis. N1: Nasopharyngeal cancer with unilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa, and/or unilateral or bilateral, retropharyngeal lymph nodes, 6 cm or less in greatest dimension. Midline nodes are considered ipsilateral nodes. N2: Nasopharyngeal cancer with bilateral metastasis in cervical lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa. Midline nodes are considered ipsilateral nodes. N3: Nasopharyngeal cancer with metastasis in a lymph node (s) more than 6 cm in greatest dimension and/or to supraclavicular fossa. Supraclavicular zone or fossa is relevant to the staging of nasopharyngeal carcinoma and is the triangular region originally described by Ho. It is defined by three points: (1) the superior margin of the sternal end of the clavicle, (2) the superior margin of the lateral end of the clavicle, (3) the point where the neck meets the shoulder. This would include caudal portions of levels IV and VB. All cases with lymph nodes (whole or part) in the fossa are considered N3b. M0: No distant metastasis. M1: Distant metastasis. (AJCC 7th ed.)] |
| Stage IV Pharyngeal Cancer | NCIT_C8771 | [Stage IV carcinoma of the pharynx according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.] |
| CTNNA1 Gene | NCIT_C88985 | [This gene is involved in cell adhesion.] |
| Cytoskeletal Gene | NCIT_C20745 | [Cytoskeletal Genes encode Cytoskeletal Proteins, diverse structural proteins including polymerizable globular subunits (actin, tubulin), "motor ATPases" (myosin, dynein), membrane-supporting linkers (spectrin, clathrin), fibrous proteins (keratin, vimentin), and many more. As constituents of the cytoskeleton, Cytoskeletal Proteins form a flexible cellular framework that provides attachment points for organelles and formed bodies and makes communication between cell parts possible. (NCI)] |
| CTNNA1 wt Allele | NCIT_C88986 | [Human CTNNA1 wild-type allele is located in the vicinity of 5q31 and is approximately 210 kb in length. This allele, which encodes catenin alpha-1 protein, plays a role in the mediation of both protein-protein interactions and cellular adhesion.] |
| Colchicum luteum Bulb | NCIT_C74360 | |
| Seed | NCIT_C73913 | |
| Dragon's Blood | NCIT_C74361 | |
| Resin | NCIT_C79662 | |
| Jalap Resin | NCIT_C74362 |